by Jazzmin Huber | Mar 24, 2023 | Clinical Trials, Research
A clinical trial in the USA is recruiting patients with osteosarcoma and other cancers to test a new drug complex called GD2 SADA: 177 Lu DOTA. This drug uses a new technology where it can disassemble and reassemble itself. By changing the way it’s constructed it can...
by Jazzmin Huber | Feb 9, 2023 | Clinical Trials, Research
Dr. Matteo Trucco, from Cleveland Clinic Children’s, has launched a sarcoma clinical trial. This clinical trial, based in the USA, aims to see if a drug called disulfiram could be repurposed to be used in sarcoma treatment. Sarcomas are a group of cancers which...
by Jazzmin Huber | Jan 31, 2023 | Clinical Trials, ONTEX, Resources and Support
Welcome to the ONTEX social media toolkit. We are delighted to have launched our new improved Osteosarcoma Now Trial EXplorer (ONTEX). Each osteosarcoma clinical trial has been summarised to give a clear picture of its aims, what it involves and who can take part. Its...
by Jazzmin Huber | Jan 20, 2023 | Clinical Trials, Resources and Support
We are delighted to launch our new improved Osteosarcoma Now Trial EXplorer (ONTEX). ONTEX is an international database that aims to make clinical trial information available and accessible to all. Each osteosarcoma clinical trial has been summarised to give a clear...
by Jazzmin Huber | Dec 6, 2022 | Clinical Trials, Research
In November 2022 we attended the Connective Tissue Oncology Society (CTOS) meeting. This meeting brought together clinicians, researchers and patient advocates dedicated to improving outcomes in sarcoma. In this blog we highlight some of the talks with a focus on...
by Jazzmin Huber | Oct 25, 2022 | Clinical Trials, Research
This October clinicians, researchers and patient advocates from across Europe came together for the first in-person FOSTER (Fighting OSteosarcoma Through European Research) meeting. The event was held over two days at the Gustave Roussy Cancer Research hospital in...
